Because there are no drugs specifically targeted toward children with DIPG, doctors use drugs, approved by the Food and Drug Administration, that are meant for adults and tailor them for children in Phase I trials. Lola decided to participate in a trial at St. Jude Children's Research Hospital in Memphis, Tenn. Even though there was no guarantee that the trial would have any effect on her tumor, Lola underwent treatment to benefit DIPG research. Sacrificing her body to potentially help the next child with DIPG was more important than her quantity of life, exemplifying Lola's selfless nature. Melissa comforts Lola after her chemotherapy medications caused vomiting. Lola learns how to grapple with the ways in which DIPG has hindered her childhood.